Labcorp Holdings (LH) Liabilities from Discontinued Operations (2017 - 2022)

Labcorp Holdings (LH) posted Liabilities from Discontinued Operations of 657600000.0 for Q4 2022, up 3155.45% sequentially from 20200000.0 in Q4 2017.

Labcorp Holdings (LH) Liabilities from Discontinued Operations (2017 - 2022) Analysis & Trends

Labcorp Holdings has reported Liabilities from Discontinued Operations for 2 years, with the latest figure at 657600000.0 in Q4 2022.

  • Quarterly Liabilities from Discontinued Operations changed N/A year-over-year to 657600000.0 in Q4 2022, while the trailing twelve-month figure through Dec 2022 was 657600000.0 (changed N/A YoY) and the FY2022 annual result came in at 657600000.0, changed N/A from the prior year.
  • Liabilities from Discontinued Operations advanced to 657600000.0 in Q4 2022 per LH's latest filing, from 20200000.0 in the prior quarter.
  • Over five years, Liabilities from Discontinued Operations peaked at 657600000.0 in Q4 2022 and troughed at 657600000.0 in Q4 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 214.22 Bn 210.16 Bn 8.34 Bn
2 Danaher 140.38 Bn 136.03 Bn 3.61 Bn
3 Idexx Laboratories 46.15 Bn 45.95 Bn 779.09 Mn
4 Agilent Technologies 39.80 Bn 37.99 Bn 990.00 Mn
5 Iqvia Holdings 39.51 Bn 37.43 Bn 1.44 Bn
6 Natera 38.83 Bn 37.73 Bn 696.04 Mn
7 Illumina 30.02 Bn 28.85 Bn 770.00 Mn
8 Mettler Toledo International 28.64 Bn 28.59 Bn 650.22 Mn
9 Quest Diagnostics 26.17 Bn 25.54 Bn 1.03 Bn
10 Labcorp Holdings 25.90 Bn 24.92 Bn 1.01 Bn

Historic Data

Download Data
DateValue
Dec 31, 2022 657.60 Mn
Dec 31, 2022 657.60 Mn
Dec 31, 2017 20.20 Mn
Dec 31, 2017 20.20 Mn